Skip to main content

Table 5 Range, mean, standard deviation (SD), and statistical analysis of LDH, ESR, S. bilirubin, D-dimer, and ABG in the three studied groups

From: Study of pulmonary hypertension in post-COVID-19 patients by transthoracic echocardiography

 

Range

Mean

 ± 

SD

F-test

p-value

  

LDH (U/L)

Group I

110

652

309.00

 ± 

188.54

21.340

0.001*

P1

0.790

Group II

150

477

291.07

 ± 

97.61

P2

0.001*

Group III

190

985

644.80

 ± 

222.70

P3

0.001*

ESR (mm/hour)

Group I

10

110

35.20

 ± 

29.75

18.705

0.001*

P1

0.002*

Group II

15

120

70.00

 ± 

34.43

P2

0.001*

Group III

25

130

97.25

 ± 

25.62

P3

0.010*

Serum bilirubin (mg/dL)

Group I

0.2

1.1

0.59

 ± 

0.30

15.183

0.001*

P1

0.003*

Group II

0.2

1.8

0.99

 ± 

0.38

P2

0.001*

Group III

0.6

2

1.25

 ± 

0.37

P3

0.034*

D-dimer (mg/ FEU)

Group I

0.2

1.5

0.59

 ± 

0.44

8.153

0.003*

P1

0.093

Group II

0.4

2.6

1.61

 ± 

0.81

P2

0.001*

Group III

0.3

9.1

2.82

 ± 

2.43

P3

0.035*

PO2 (mmHg)

Group I

60

98

76.40

 ± 

11.62

86.408

0.001*

P1

0.009*

Group II

60

80

68.42

 ± 

5.88

P2

0.001*

Group III

38

59

42.83

 ± 

5.68

P3

0.001*

SO2%

Group I

93

98

95.87

 ± 

1.41

72.088

0.001*

P1

0.011*

Group II

83

98

91.45

 ± 

4.79

P2

0.001*

Group III

70.8

89

78.16

 ± 

5.80

P3

0.001*

HCO3 (mEq/L)

Group I

12

28

24.23

 ± 

4.59

0.341

0.713

P1

0.451

Group II

22

29

25.40

 ± 

2.50

P2

0.894

Group III

12

29

24.43

 ± 

4.86

P3

0.501

PH

Group I

7.3

7.6

7.43

 ± 

0.09

0.815

0.449

P1

0.373

Group II

7.42

7.53

7.47

 ± 

0.03

P2

0.219

Group III

7

7.7

7.48

 ± 

0.15

P3

0.777

PCO2 (mmHg)

Group I

18

40

32.07

 ± 

6.79

0.245

0.784

P1

0.841

Group II

26

42

32.67

 ± 

5.25

P2

0.649

Group III

15

60

30.80

 ± 

10.44

P3

0.503

  1. *Significant as p-value ≤ 0.05 (LDH lactate dehydrogenase, ESR erythrocyte sedimentation rate)